Periodontal tissue disposition of azithromycin

Journal of Periodontology

Volumn 68, Issue 12, 1997, Pages 1206-1209

  Malizia, Tecla ^a   Tejada, Milvana R ^a   Ghelardi, Emilia ^a   Senesi, Sonia ^a   Gabriele, Mario ^b   Giuca, Maria R ^b   Blandizzi, Corrado ^c   Danesi, Romano ^c   Campa, Mario ^a   Del Tacca, Mario ^a,c  

^a UNIVERSITY OF PISA   (Italy)

^b Istituto di Clinica Odontoiatrica

^c Istituto di Radiologia   (Italy)

Author keywords

Azithromycin therapeutic use; Gingiva microbiology; Periodontium microbiology; Plasma mic robiology; Saliva microbiology

Indexed keywords

AZITHROMYCIN; MACROLIDE;

ADULT; ALVEOLAR BONE; ARTICLE; CLINICAL ARTICLE; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG DISPOSITION; DRUG SALIVA LEVEL; DRUG TISSUE LEVEL; FEMALE; GINGIVA; HUMAN; MALE; PERIODONTITIS; TOOTH EXTRACTION;

EID: 6844250096     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.1997.68.12.1206     Document Type: Article

References (12)

1. Williams JD, Maskell JP, Shain H, et al. Comparative in vitro activity of azithromycin, macrolides (erythromycin, clarithromycin and spiramycin) and streptogramin RP 59500 against oral organisms. J Antimicrob Chemother 1992;30:27-37.
2. Del Tacca M, Danesi R, Bernardini N, et al. Roxithromycin penetration into gingiva and alveolar bone of odontoiatric patients. Chemotherapy 1990;36:332-336.
3. Peters DH, Friedel HA, McTavish D, Azithromycin. A review of its antimicrobial activity, pharmacokinetic properties and clinical efficacy. Drugs 1992;44:750-799.
4. Foulds G, Johnson RB. Selection of dose regimens of azithromycin. J Antimicrob Chemother 1993;31(Suppl. E):39-50.
5. Lo Bue AM, Sammartino R, Chisari G, Gismondo MR, Nicoletti G. Efficacy of azithromycin compared with spiramycin in the treatment of odontogenic infections. J Antimicrob Chemother 1993;31(Suppl. E): 119-127.
6. Torres JH, Bons P, Vayssiere J, Blayac J-P, Boucard R. Interactions medicamenteuses en odonto-stomatologie. Actual Odonto-Stomatol 1990;171:407-413.
7. Campa M, Zolfino I, Senesi S, et al. The penetration of roxithromycin into human skin. J Antimicrob Chemother 1990;26:87-90.
8. Shepard RM, Falkner FC. Pharmacokinetics of azithromycin in rats and dogs. J Antimicrob Chemother 1990; 25(Suppl. A):49-60.
9. Markham A, Faulds D. Roxithromycin. An update of its antimicrobial activity, pharmacokinetic properties and therapeutic use. Drugs 1994;48:297-326.
10. Del Tacca M, Danesi R, Blandizzi C, et al. Periodontal tissue distribution of cefpodoxime proxetil and efficacy in acute odontogenic infections. Drug Invest 1993;5:313-319.
11. Foulds G, Shepard RM, Johnson RB. The pharmacokinetics of azithromycin in human serum and tissues. J Antimicrob Chemother 1990; 25(Suppl. A):73-82.
12. Karma P Pukander J, Penntila M. Azithromycin concentration in sinus fluid and mucosa after oral administration. Eur J Clin Microbiol Infect Dis 1991;10:856-859.